Antigen-presenting-cell-associated programs in thymoma-associated myasthenia gravis: public transcriptomic reanalysis and archived cell-model observations.
Thymoma-associated myasthenia gravis (TAMG) involves a complex thymic immune environment, but tissue antigen-presenting-cell (APC) programs do not by themselves establish a soluble-signal mechanism. We re-analyzed public single-cell and spatial transcriptomic data and examined archived records from…
Immune checkpoint inhibitor induced Triple-M syndrome: A case series detailing what every ophthalmologist should know.
Immunotherapy has revolutionized cancer treatment but has also been associated with various immune-related adverse events. Triple M syndrome is a particularly rare and life-threatening adverse effect, which encompasses the overlap of immune checkpoint inhibitor-induced myasthenia gravis, myositis, a…
A case report of sporadic Creutzfeldt-Jakob disease presenting with progressive opsoclonus-myoclonus-ataxia-Plus (OMAS-Plus) phenotype.
Sporadic Creutzfeldt-Jakob disease (sCJD) is a rapidly progressive prion disorder whose heterogeneous manifestations may overlap with potentially treatable neurological conditions. We report an atypical sCJD phenotype dominated by progressive dysarthria and an opsoclonus-myoclonus-ataxia-plus (OMAS-…
Hospital resource utilization in patients with generalized myasthenia gravis treated with nipocalimab: results from the VIVACITY-MG3 study.
Generalized myasthenia gravis (gMG) is a rare, chronic autoimmune disorder with substantial healthcare resource utilization (HRU) and high economic burden. This study evaluated HRU, costs, and predictors of high-cost events in adults with gMG, using data from VIVACITY-MG3. Post-hoc analyses used the…
Investigating and validating the molecular mechanisms of lipid metabolism regulation in myasthenia gravis development based on single-cell, bulk transcriptomics, and RT-qPCR.
Myasthenia gravis (MG) is a complex autoimmune neuromuscular disorder, and the role of lipid metabolism dysregulation in MG pathogenesis remains unclear. This study aimed to investigate the molecular mechanisms of lipid metabolism regulation in myasthenia gravis development by integrating single-cel…
Anti-C2-mediated complement inhibition prevents disease in a rat passive transfer model of myasthenia gravis.
Acetylcholine receptor antibody-positive myasthenia gravis (AChR-MG) is a rare autoimmune disease in which AChR autoantibodies trigger complement activation and cause damage to the neuromuscular junction. This study evaluated the therapeutic potential of an anti-C2 antibody in the rat passive transf…
Primigravida with generalized myasthenia gravis leading to caesarean section delivery: a case report.
Myasthenia gravis (MG) is a chronic autoimmune disorder affecting the neuromuscular junction, characterized by fluctuating muscle weakness. Pregnancy in women with MG poses unique challenges, as physiological and immunological changes may influence disease activity and obstetric outcomes. A 25-year-…